Medical Physics, AI and Neurotechnology · University of Rome Tor Vergata

fismed@uniroma2.it

FISMED / PEOPLE

Bilal Nizami

Doctoral Researcher · University of Rome Tor Vergata

BACKGROUND

Biography

Bilal Nizami is a doctoral researcher at the University of Rome Tor Vergata, studying focused ultrasound for blood–brain barrier modulation and drug delivery. His work also examines nanoparticle-mediated neuromodulation. He holds a Doctor of Pharmacy degree from the University of Karachi and an Erasmus Mundus master's degree in Nanomedicine. His master's research at Heidelberg University investigated a human stem-cell-derived model of the blood–brain barrier. He publishes as Syed Bilal Nizami.

RESEARCH & EXPERTISE

Research interests

  • Blood–brain barrier
  • Focused ultrasound
  • Drug delivery
  • Nanoparticle-mediated neuromodulation

RESEARCH OUTPUT

Selected publications

  1. Ex vivo localization of wireless implantable microdevice using high-resolution 3D imaging techniques.Frontiers in bioengineering and biotechnology · 2026
    The CROSSBRAIN EU project aims to address the heterogeneous nature of brain pathologies by developing wireless implantable microbots (µBots, planned dimensions 100 × 100 × 100 μm3) for highly localized neuromodulation. These devices are designed to precisely modulate brain activity with minimal invasiveness, enabling targeted resolution of specific spatiotemporal events, capabilities not currently achieved by existing neuromodulation technologies. A crucial step involves visualizing and ensuring the optimal placement of the µBots in the brain tissue, to study their functionality after implantation. In this preliminary ex vivo study, we used non-functional µBot silicon (Si) dummies matching the lateral dimensions of the intended µBots, with reduced thickness (100 × 100 × 50 μm3) to simplify fabrication and handling. Due to the intrinsic MRI incompatibility of the µBot platform, encompassing both the dummies used in this study and the future functional devices under development, and the limitations of standard histological approaches in reliably identifying and preserving the implant site during processing, we developed an integrated imaging workflow combining 2D and 3D techniques. While standard histological methods and tissue clearing presented substantial limitations in preserving the position of the dummies within the brain tissue, combining histological techniques with 3D X-ray tomography provided a robust strategy. In particular, synchrotron radiation-based X-ray Phase Contrast Tomography (XPCT), with its intrinsic high contrast and resolution, enabled detailed visualization of dummies within the surrounding vascular and cellular architecture. In contrast, conventional micro-Computed Tomography (micro-CT), although more widely accessible, enabled non-destructive guidance for targeted sectioning. Importantly, and in line with the scope of a Brief Research Report, this study presents a preliminary but technically robust investigation conducted within the CROSSBRAIN project, aimed at identifying and establishing an optimized imaging strategy for the visualization of implanted µBots in brain tissue. This methodological framework is intended as an initial step toward future in vivo studies, in which the validated imaging pipeline will be applied to track both dummy and functional devices and to enable subsequent evaluation of foreign body response under physiologically relevant conditions. This ex vivo workflow therefore provides the essential technical foundation for such future investigations and supports the clear positioning of this work as a feasibility and optimization study. This approach could be particularly valuable for new generations of implantable technologies incompatible with MRI and could support future development of personalized neuromodulation therapies by enabling precise device localization and structural tissue assessment.
  2. Ultrasound-Assisted multimodal neuromodulation via nanosystems.Journal of nanobiotechnology · 2026
    Neuromodulation techniques have emerged as transformative tools for treating several neurological and psychiatric disorders, offering alternatives to traditional pharmacological approaches often hindered by the blood-brain barrier and off-target effects. While conventional modalities like deep brain stimulation, transcranial magnetic stimulation, and optogenetics have shown promise, they each face limitations in invasiveness, spatial resolution, or clinical applicability. In recent years, low-intensity ultrasound has gained attention as a noninvasive, deep-penetrating modality capable of modulating brain circuits with millimeter-sized spatial precision. This review explores the synergistic integration of ultrasound with engineered nanosystems to achieve multimodal neuromodulation such as electrical, mechanical, optical, and chemical via acoustic energy. We describe how nanoscale materials can transduce ultrasound into localized bioelectric signals, mechanical stress, light emission, or controlled drug release. These interactions enable precise, on-demand stimulation or inhibition of neuronal activity, including in deep brain regions. Experimental studies have demonstrated neuromodulatory effects across a variety of models, with applications ranging from optogenetics and drug delivery to behavioral modulation in rodents and primates. The review concludes with a critical assessment of the translational challenges such as nanoparticle delivery, biocompatibility, long-term clearance, and safety thresholds for human use while outlining promising strategies like cell-based delivery, biodegradable materials, and closed-loop control systems. These innovations highlight the potential of ultrasound-assisted nanosystems as transformative tools for precise neuromodulation in both experimental neuroscience and clinical applications.
  3. Magnetite nanodiscs as vortex-enhanced MRI contrast agents: a novel approach in medical imaging.Nanoscale advances · 2026
    Magnetic nanodiscs (MNDs) represent a transformative class of anisotropic magnetic nanoparticles with intrinsic vortex magnetization, enabling multifunctional applications in biomedical imaging and therapy. Here, we demonstrate their potential as dual-mode magnetic resonance (MR) contrast agents, a unique feature which is enabled by the high longitudinal relaxivity (r 1 ≈ 40 mM-1 s-1) at ultralow magnetic fields (<70 µT) in combination with strong transverse relaxivity (r 2 > 150 mM-1 s-1) at ultrahigh fields (>7 T). This field-dependent relaxivity profile uniquely positions MNDs as versatile T 1/T 2 agents compatible with emerging low-field MRI platforms and high-resolution clinical systems. Ex vivo and in vivo assessments confirmed clear anatomical localization and preferential hepatic accumulation, suggesting prolonged circulation times due to surface-mediated immune evasion. These properties highlight MNDs as promising candidates for next-generation theranostics, with tunable magnetic responses, high contrast efficiency, and the ability to synergize imaging and neurostimulation.

LABORATORIES & RESEARCH

Related research

Back to researchers and staff